Longbio Pharma
Longbio Pharma
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Single Dose of LP-003 in Adolescent Subjects | Allergic Diseases | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-17 | NCT07148557 | |
| A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Not yet recruiting | Phase 2 | 2026-02-06 | NCT07313917 | |
| Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease | Complement-mediated Renal Diseases | Not yet recruiting | Phase 2 | 2026-01-23 | NCT07363265 | |
| Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome | Active, not recruiting | Phase 2 | 2026-01-16 | NCT07212426 | |
| Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients | allergic asthma | Recruiting | Phase 2 | 2026-01-15 | NCT07342803 | |
| Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Active, not recruiting | Phase 3 | 2025-12-26 | NCT07291284 | |
| A Study of Single Dose of LP-003 in Healthy Adult Subjects | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Active, not recruiting | Phase 1 | 2025-12-18 | NCT06604949 | |
| Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Not yet recruiting | Phase 2 | 2025-12-05 | NCT07266155 |